A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202

被引：0
作者：
Syma Iqbal
Cathryn Rankin
Heinz-Josef Lenz
Philip J. Gold
Syed A. Ahmad
Anthony B. El-Khoueiry
Michael J. Messino
Randall F. Holcombe
Charles D. Blanke
机构：
[1] University of Southern California,Norris Comprehensive Cancer Center
[2] Southwest Oncology Group Statistical Center,Barrett Center, Department of Surgery
[3] Swedish Cancer Institute,undefined
[4] University of Cincinnati,undefined
[5] Southeast Cancer Control Consortium,undefined
[6] Inc. CCOP,undefined
[7] Cancer Care of WNC,undefined
[8] University of California at Irvine,undefined
[9] Chao Family CCC,undefined
[10] University of British Columbia,undefined
[11] and British Columbia Cancer Agency,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 68卷
关键词：
Gemcitabine; Capecitabine; Cholangiocarcinoma; Gallbladder; Clinical trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1595 / 1602
页数：7
相关论文
共 50 条
  • [31] Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
    Roberto Petrioli
    Giandomenico Roviello
    Anna Ida Fiaschi
    Letizia Laera
    Daniele Marrelli
    Franco Roviello
    Edoardo Francini
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 683 - 690
  • [32] Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
    H J Stemmler
    D diGioia
    W Freier
    H W Tessen
    G Gitsch
    W Jonat
    W Brugger
    E Kettner
    W Abenhardt
    H Tesch
    H J Hurtz
    S Rösel
    O Brudler
    V Heinemann
    British Journal of Cancer, 2011, 104 : 1071 - 1078
  • [33] A phase II trial of a combination of pemetrexed and gemcitabine in patients with metastatic breast cancer: an NCCTG study
    Ma, CX
    Steen, P
    Rowland, KM
    Niedringhaus, RD
    Fitch, TR
    Kugler, JW
    Hillman, DW
    Perez, EA
    Ingle, JN
    Adjei, AA
    ANNALS OF ONCOLOGY, 2006, 17 (02) : 226 - 231
  • [34] Gemcitabine and Cisplatin for Patients with Metastatic or Recurrent Esophageal Carcinoma: A Southwest Oncology Group Study
    Susan G. Urba
    Kari Chansky
    Peter J. vanVeldhuizen
    Robert E. Pluenneke
    Jacqueline K. Benedetti
    John S. Macdonald
    James L. Abbruzzese
    Investigational New Drugs, 2004, 22 : 91 - 97
  • [35] Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial
    Joung-Soon Jang
    Ho Yeong Lim
    In Gyu Hwang
    Hong Suk Song
    NaeChoon Yoo
    SoYoung Yoon
    Yeul Hong Kim
    Eunsik Park
    Jae Ho Byun
    Myung Ah Lee
    Suk Joong Oh
    Kyung Hee Lee
    Bong Seog Kim
    Sang Cheul Oh
    Sam Yong Kim
    Sang Jae Lee
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 641 - 647
  • [36] Gemcitabine and Cisplatin for patients with metastatic or recurrent esophageal carcinoma: A Southwest Oncology Group study
    Urba, SG
    Chansky, K
    vanVeldhuizen, PJ
    Pluenneke, RE
    Benedetti, JK
    Macdonald, JS
    Abbruzzese, JL
    INVESTIGATIONAL NEW DRUGS, 2004, 22 (01) : 91 - 97
  • [37] A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients
    Santini, Daniele
    Virzi, Vladimir
    Vasile, Enrico
    Vincenzi, Bruno
    Catalano, Vincenzo
    Graziano, Francesco
    Masi, Gianluca
    Bronte, Giuseppe
    Russo, Antonio
    Falcone, Alfredo
    Tonini, Giuseppe
    ONCOLOGY, 2012, 82 (02) : 75 - 82
  • [38] Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial)
    Ciruelos, E. M.
    Cortes, J.
    Cortes-Funes, H.
    Mayordomo, J. I.
    Bermejo, B.
    Ojeda, B.
    Garcia, E.
    Rodriguez, C. A.
    Munoz, M.
    Gomez, P.
    Manso, L.
    Andres, R.
    Lluch, A.
    Saura, C.
    Mendiola, C.
    Baselga, J.
    ANNALS OF ONCOLOGY, 2010, 21 (07) : 1442 - 1447
  • [39] A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer
    Oettle, H
    Richards, D
    Ramanathan, RK
    van Laethem, JL
    Peeters, M
    Fuchs, M
    Zimmermann, A
    John, W
    Von Hoff, D
    Arning, M
    Kindler, HL
    ANNALS OF ONCOLOGY, 2005, 16 (10) : 1639 - 1645
  • [40] A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumbab for Locally Advanced or Metastatic Biliary Tract Cancer
    Iyer, Renuka V.
    Pokuri, Venkata K.
    Groman, Adrienne
    Ma, Wen W.
    Malhotra, Usha
    Iancu, Dan M.
    Grande, Catherine
    Saab, Tanios B.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (07): : 649 - 655
12345